These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1322657)

  • 21. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.
    Toyosaki T; Miyazawa T; Furuya T; Tomonaga K; Shin YS; Okita M; Kawaguchi Y; Kai C; Mori S; Mikami T
    Arch Virol; 1993; 131(3-4):335-47. PubMed ID: 8102229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization and heterogeneity of feline immunodeficiency virus isolates.
    Maki N; Miyazawa T; Fukasawa M; Hasegawa A; Hayami M; Miki K; Mikami T
    Arch Virol; 1992; 123(1-2):29-45. PubMed ID: 1312825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 8-Difluoromethoxy-4-quinolone derivatives as anti-feline immunodeficiency virus (FIV) agents: important structural features for inhibitory activity of FIV replication.
    Kashiwase H; Katsube T; Kimura T; Nishigaki T; Yamashita M
    J Vet Med Sci; 2000 May; 62(5):499-504. PubMed ID: 10852398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
    Waters AK; De Parseval AP; Lerner DL; Neil JC; Thompson FJ; Elder JH
    Virology; 1996 Jan; 215(1):10-6. PubMed ID: 8553580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of feline immunodeficiency virus from a chronically infected feline T-lymphocyte cell line.
    Tochikura TS; Naito Y; Kozutsumi Y; Hohdatsu T
    Res Vet Sci; 2012 Apr; 92(2):327-32. PubMed ID: 21477828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus.
    Willett BJ; Adema K; Heveker N; Brelot A; Picard L; Alizon M; Turner JD; Hoxie JA; Peiper S; Neil JC; Hosie MJ
    J Virol; 1998 Aug; 72(8):6475-81. PubMed ID: 9658090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of high virus neutralizing antibody titers in cats experimentally infected with feline immunodeficiency virus.
    Inoshima Y; Ikeda Y; Kohmoto M; Pecoraro MR; Shimojima M; Shimojima Y; Inada G; Kawaguchi Y; Tomonaga K; Miyazawa T; Mikami T
    J Vet Med Sci; 1996 Sep; 58(9):925-7. PubMed ID: 8898296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
    Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate.
    Miyazawa T; Fukasawa M; Hasegawa A; Maki N; Ikuta K; Takahashi E; Hayami M; Mikami T
    J Virol; 1991 Mar; 65(3):1572-7. PubMed ID: 1847473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of apoptosis and virus replication in feline immunodeficiency virus-infected cells by N-acetylcysteine and ascorbic acid.
    Mortola E; Okuda M; Ohno K; Watari T; Tsujimoto H; Hasegawa A
    J Vet Med Sci; 1998 Nov; 60(11):1187-93. PubMed ID: 9853298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feline immunodeficiency virus can infect a human cell line (MOLT-4) but establishes a state of latency in the cells.
    Ikeda Y; Tomonaga K; Kawaguchi Y; Kohmoto M; Inoshima Y; Tohya Y; Miyazawa T; Kai C; Mikami T
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1623-30. PubMed ID: 8760408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
    Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
    Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells.
    Lerner DL; Elder JH
    J Virol; 2000 Feb; 74(4):1854-63. PubMed ID: 10644358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.
    Beebe AM; Faith TG; Sparger EE; Torten M; Pedersen NC; Dandekar S
    AIDS; 1994 Jul; 8(7):873-8. PubMed ID: 7946095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes.
    Miyazawa T; Kohmoto M; Kawaguchi Y; Tomonaga K; Toyosaki T; Ikuta K; Adachi A; Mikami T
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1573-80. PubMed ID: 8393913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered cell tropism and cytopathicity of feline immunodeficiency viruses in two different feline CD4-positive, CD8-negative cell lines.
    Tokunaga K; Nishino Y; Oikawa H; Ishihara C; Mikami T; Ikuta K
    J Virol; 1992 Jun; 66(6):3893-8. PubMed ID: 1374812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes.
    Nakagaki K; Nakagaki K; Takahashi K; Schols D; De Clercq E; Tabira T
    J Neurovirol; 2001 Oct; 7(5):487-92. PubMed ID: 11582522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Feline immunodeficiency virus infection: interferon gamma secretion in a T-lymphoblastoid infected cell line].
    Mórtola EC; Endo Y; Zuccolilli GO; Gimeno EJ
    Rev Argent Microbiol; 1999; 31(3):127-34. PubMed ID: 10509391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells.
    Rideout D; Schinazi R; Pauza CD; Lovelace K; Chiang LC; Calogeropoulou T; McCarthy M; Elder JH
    J Cell Biochem; 1993 Apr; 51(4):446-57. PubMed ID: 7684385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.